subject hicn medic new part cut here volum number april health info com network medic newslett editor david dodel d m d north nd street suit scottsdal arizona usa telephon fax compil copyright by david dodel d m d all right reserv licens is herebi grant to republish on electron media for which no fee ar charg so long as the text of thi copyright notic and licens ar attach intact to ani and all republish portion or portion the health info com network newslett is distribut biweekli articl on a medic natur ar welcom if you have an articl pleas contact the editor for inform on how to submit it if you ar interest in join the autom distribut system pleas contact the editor e mail address editor internet david stat com fidonet bitnet atw h asuacad listserv mednew asuacad bitnet or internet mednew asuvm inr asu edu anonym ftp vm nodak edu notif list hicn notifi request stat com fax deliveri contact editor for inform t a b l e o f c o n t e n t s center for diseas control and prevent mmwr april rate of cesarean deliveri malaria among u s embassi personnel fda approv of hib vaccin for children infant dental new workshop explor oral manifest of hiv infect food drug administr new fda approv depo provera inject contracept new rule speed approv of drug for life threaten ill articl research promis prevent slow blind from retin diseas affluent diet increas risk of heart diseas gener announc public for health profession from nation cancer institut public for patient avail from nation cancer institut aid new summari aid daili summari for april to april aid statist worldwid aid statist hicnet medic newslett page i volum number april center for diseas control and prevent mmwr rate of cesarean deliveri unit state sourc mmwr date apr cesarean deliveri have account for nearli million of the approxim million annual deliveri in the unit state sinc tabl the cesarean rate in the unit state is the third highest among report countri exceed onli by brazil and puerto rico thi report present data on cesarean deliveri from cdc s nation hospit discharg survei nhd for and compar these data with previou year data on discharg from short stai nonfeder hospit have been collect annual sinc in the nhd conduct by cdc s nation center for health statist for medic and demograph inform were abstract from a sampl of inpati discharg from particip hospit the cesarean and vagin birth after a prior cesarean vbac present in thi report ar base on weight nation estim from the nhd sampl of approxim women discharg after deliveri the estim number of live birth by type of deliveri were calcul by appli cesarean rate from the nhd to live birth from nation vital registr data therefor estim of the number of cesarean in thi report will not agre with previous publish data base sole on the nhd state differ in thi analysi ar signific at the confid level base on the two tail t test with a critic valu of in there were cesarean per deliveri the same rate as in and similar to rate dure tabl the primari cesarean rate i e number of first cesarean per deliveri to women who had no previou cesarean for also wa stabl rang from to in the cesarean rate in the south wa significantli p higher than the rate for the west midwest and northeast rate were higher for mother ag greater than or equal to year than for younger women in proprietari hospit than in nonprofit or govern hospit in hospit with fewer than bed than in larger hospit and for deliveri for which blue cross blue shield and other privat insur is the expect sourc of payment than for other sourc of payment tabl the same pattern character primari cesarean deliveri sinc the earli s the number and percentag of birth to older women increas howev if the ag distribut of mother in had remain the same as in the overal cesarean rate in would have been essenti the same as the observ base on the nhd of the approxim live birth in an hicnet medic newslett page volum number april estim were by cesarean deliveri of these an estim birth were repeat cesarean and were primari cesarean sinc approxim primari cesarean have been perform annual in of women who had a previou cesarean deliv vagin compar with in of all cesarean in were associ with a previou cesarean with dystocia i e failur of labor to progress with breech present with fetal distress and with all other specifi complic the averag hospit stai for all deliveri in wa dai in comparison the hospit stai for a primari cesarean deliveri wa dai and for a repeat cesarean dai nearli twice the durat for vbac deliveri dai or for vagin deliveri that were not vbac dai in the averag hospit stai for all deliveri wa dai for primari cesarean dai for repeat cesarean dai and for vbac and non vbac vagin deliveri and dai respect report by offic of vital and health statist system nation center for health statist cdc editori note the cesarean rate in the unit state steadili increas from through howev the find in thi report indic that rate have been stabl sinc becaus there is littl evid that matern and child health statu ha improv dure thi time and becaus cesarean ar associ with an increas risk for complic of childbirth a nation health object for the year is to reduc the overal cesarean rate to or fewer per deliveri and the primari cesarean rate to or fewer per deliveri object postpartum complic includ urinari tract and wound infect mai account in part for the longer hospit stai for cesarean deliveri than for vagin birth moreov the prolong hospit stai for cesarean deliveri substanti increas health care cost for exampl in the averag cost for cesarean and vagin deliveri were and respect the addit cost for each cesarean deliveri includ for physician fee and for hospit charg if the cesarean rate in had been the year object instead of the number of cesarean birth would have decreas by versu result in a save of more than billion in physician fee and hospit charg despit the steadi increas in vbac rate sinc sever factor mai imped progress toward the year nation health object for cesarean deliveri for exampl vbac rate substanti reflect the number of women offer trial of labor which ha been increasingli encourag sinc of women who ar offer a trial of labor could deliv vagin a level alreadi achiev by mani hospit trial of labor wa routin offer in of hospit survei in the most recent year for which hicnet medic newslett page volum number april nation data ar avail when the vbac rate accord to nhd data wa the year object specifi a vbac rate of base on all women who had a prior cesarean regardless of whether a trial of labor wa attempt to reach the overal cesarean rate goal howev increas in the vbac rate will need to be combin with a substanti reduct in the primari rate on hospit succeed in reduc the rate of cesarean deliveri by appli object criteria for the four most common indic for cesarean deliveri by requir a second opinion and by institut a peer review process other recommend for decreas cesarean deliveri rate includ elimin incent for physician and hospit by equal reimburs for vagin and cesarean deliveri public dissemin of physician and hospit specif cesarean deliveri rate to increas public awar of differ in practic and address malpractic concern which mai be an import factor in maintain the high rate of cesarean deliveri refer notzon fc intern differ in the us of obstetr intervent jama grave ej nch summari nation hospit discharg survei hyattsvil maryland us depart of health and human servic public health servic cdc advanc data no taffel sm placek pj kosari cl u s cesarean section rate an updat birth public health servic healthi peopl nation health promot and diseas prevent object full report with commentari washington dc us depart of health and human servic public health servic dhh public no ph danforth dn cesarean section jama hospit insur associ of america tabl cost of matern care physician fee and hospit charg by censu region base on consum price index in sourc book of health insur data washington dc hospit insur associ of america committe on obstetr acog committe opinion no guidelin for vagin deliveri after a previou cesarean birth washington dc american colleg of obstetrician and gynecologist hicnet medic newslett page volum number april rosen mg dickinson jc vagin birth after cesarean a meta analysi of indic for success obstet gynecol shiono ph fielden jg mcnelli d rhoad gg pears wh recent trend in cesarean birth and trial of labor rate in the unit state jama myer sa gleicher n a success program to lower cesarean section rate n engl j med us of trade name and commerci sourc is for identif onli and doe not impli endors by the public health servic or the u s depart of health and human servic hicnet medic newslett page volum number april malaria among u s embassi personnel kampala uganda sourc mmwr date apr the treatment and prevent of malaria in africa ha becom a challeng and complex problem becaus of increas drug resist although the risk of acquir malaria for u s citizen and their depend station oversea gener ha been low thi risk vari substanti and unpredict dure mai the offic of medic servic depart of state om do and cdc were notifi of an increas number of malaria case among offici u s personnel station in kampala uganda a review of the health record from the embassi health unit ehu in kampala indic that case of malaria were diagnos in offici personnel from march through june compar with two case dure the same period in ehu om do and cdc conduct an investig to confirm all report malaria case and identifi potenti risk factor for malaria among u s embassi personnel thi report summar the result of the investig malaria blood smear from of the report case patient were avail for review by om do and cdc a case of malaria wa confirm if the slide wa posit for plasmodium sp of the person were slide confirm as have malaria a questionnair wa distribut to all person serv by the ehu to obtain inform about resid activ us of malaria chemoprophylaxi and us of person protect measur i e us bednet and insect repel have window and door screen and wear long sleev and pant in the even of the person elig for the survei respond risk for malaria wa not associ with sex or locat of resid in kampala although the risk for malaria wa higher among children ag less than or equal to year than among person greater than year thi differ wa not signific rel risk rr confid interv ci eighti two percent of the case occur among person who had been live in kampala for year compar with those live there less than year travel outsid of the kampala area to more rural set wa not associ with increas risk for malaria four malaria chemoprophylaxi regimen were us by person who particip in the survei mefloquin chloroquin and proguanil chloroquin alon and proguanil alon in addit person who respond were not us ani malaria chemoprophylaxi the risk for malaria wa significantli lower among person us either mefloquin or chloroquin and proguanil than among person us the other regimen or no prophylaxi rr ci twelv person not us prophylaxi report side effect or fear of possibl side effect as a reason the risk for malaria wa lower among person who report us bednet hicnet medic newslett page volum number april all or most of the time than among person who sometim or rare us bednet rr ci the risk for malaria wa also lower among person who consist us insect repel in the even compar with those who rare us repel rr upper confid limit risk for malaria wa not associ with failur to have window or door screen or wear long sleev or pant in the even as a result of thi investig ehu staff review with all personnel the need to us and compli with the recommend malaria chemoprophylaxi regimen ehu staff also emphas the need to us person protect measur and made plan to obtain insecticid impregn bednet and to provid window and door screen for all personnel report by u s embassi health unit kampala uganda offic of medic svc dept of state washington d c malaria br div of parasit diseas nation center for infecti diseas cdc editori note in uganda the increas in malaria among u s personnel wa attribut to poor adher to both recommend malaria chemoprophylaxi regimen and us of person protect measur dure a period of increas malaria transmiss and intensifi chloroquin resist in sub saharan africa the find in thi report underscor the need to provid initi and continu counsel regard malaria prevent for person live abroad in malaria endem area prevent measur that ar also import for short term travel to such area mefloquin is an effect prophylaxi regimen in africa and in most other area with chloroquin resist p falciparum howev in some area e g thailand resist to mefloquin mai limit it effect in africa the efficaci of mefloquin compar with chloroquin alon in prevent infect with p falciparum is mefloquin is safe and well toler when given at mg per week over a year period the risk for seriou advers reaction possibl associ with mefloquin prophylaxi e g psychosi and convuls is low i e episod per user while the risk for less sever advers reaction e g dizzi gastrointestin complaint and sleep disturb is similar to that for other antimalari chemoprophylact doxycyclin ha similar prophylact efficaci to mefloquin but the need for daili dose mai reduc complianc with and effect of thi regimen chloroquin alon is not effect as prophylaxi in area of intens chloroquin resist e g southeast asia and africa in africa for person who cannot take mefloquin or doxycyclin chloroquin and proguanil is an altern although less effect regimen chloroquin should be us for malaria prevent in area onli where chloroquin resist p falciparum ha not been report countri specif recommend for prevent malaria and inform hicnet medic newslett page volum number april on the dosag and precaut for malaria chemoprophylaxi regimen ar avail from health inform for intern travel i e yellow book or hour a dai by telephon or fax refer lobel ho miani m eng t et al long term malaria prophylaxi with weekli mefloquin in peac corp volunt an effect and well toler regimen lancet world health organ review of central nervou system advers event relat to the antimalari drug mefloquin geneva world health organ public no who mal pang l limsomwong n singharaj p prophylact treatment of vivax and falciparum malaria with low dose doxycyclin j infect di pang l limsomwong n boudreau ef singharaj p doxycyclin prophylaxi for falciparum malaria lancet cdc health inform for intern travel atlanta us depart of health and human servic public health servic dhh public no cdc hicnet medic newslett page volum number april fda approv of us of a new haemophilu b conjug vaccin and a combin diphtheria tetanu pertussi and haemophilu b conjug vaccin for infant and children sourc mmwr date apr haemophilu influenza type b hib conjug vaccin have been recommend for us in infant sinc and their routin us in infant vaccin ha contribut to the substanti declin in the incid of hib diseas in the unit state vaccin against diphtheria tetanu and pertussi dure infanc and childhood have been administ routin in the unit state sinc the late s and ha been associ with a greater than reduct in morbid and mortal associ with infect by these organ becaus of the increas number of vaccin now routin recommend for infant a high prioriti is the develop of combin vaccin that allow simultan administr with fewer separ inject the food and drug administr fda recent licens two new product for vaccin children against these diseas the haemophilu b conjug vaccin tetanu toxoid conjug acthib trademark for vaccin against hib diseas onli and a combin diphtheria and tetanu toxoid and whole cell pertussi vaccin dtp and hib conjug vaccin tetramun trademark a combin of vaccin formul for us in vaccin children against diphtheria tetanu pertussi and hib diseas acthib trademark on march the fda approv a new haemophilu b conjug vaccin polyribosylribitol phosphat tetanu toxoid conjug prp t manufactur by pasteur merieux serum et vaccin and distribut as acthib trademark by connaught laboratori inc swiftwat pennsylvania thi vaccin ha been licens for us in infant in a three dose primari vaccin seri administ at ag and month previous unvaccin infant month of ag should receiv two dose month apart previous unvaccin children month of ag should receiv on dose a booster dose administ at month of ag is recommend for all children previous unvaccin children month of ag should receiv a singl dose and do not requir a booster more than of infant receiv a primari vaccin seri of acthib trademark consecut dose at and month of ag develop a geometr mean titer of anti haemophilu b polysaccharid antibodi greater than ug ml thi respons is similar to that of infant who receiv recommend seri of previous licens haemophilu b conjug vaccin for which efficaci ha been demonstr in prospect trial two u s efficaci trial of prp t were termin earli becaus of the concomit licensur of other haemophilu b conjug vaccin hicnet medic newslett page volum number april for us in infant in these studi no case of invas hib diseas were detect in approxim infant vaccin with prp t these and other studi suggest that the efficaci of prp t vaccin will be similar to that of the other licens hib vaccin tetramun trademark on march the fda approv a combin diphtheria and tetanu toxoid and whole cell pertussi vaccin dtp and haemophilu b conjug vaccin tetramun trademark avail from lederl praxi biolog pearl river new york combin two previous licens product dtp triimmunol regist manufactur by lederl laboratori pearl river new york and haemophilu b conjug vaccin hibtit regist manufactur by praxi biolog inc rochest new york thi vaccin ha been licens for us in children ag month year for protect against diphtheria tetanu pertussi and hib diseas when indic for vaccin with dtp vaccin and haemophilu b conjug vaccin coincid base on demonstr of co mparabl or higher antibodi respons to each of the compon of the two vaccin tetramun trademark is expect to provid protect against hib as well as diphtheria tetanu and pertussi equival to that of alreadi licens formul of other dtp and haemophilu b vaccin the advisori committe for immun practic acip recommend that all infant receiv a primari seri of on of the licens haemophilu b conjug vaccin begin at month of ag and a booster dose at ag month the acip also recommend that all infant receiv a four dose primari seri of diphtheria and tetanu toxoid and pertussi vaccin at and month of ag and a booster dose at year a complet statement regard recommend for us of acthib trademark and tetramun trademark is be develop report by offic of vaccin research and review center for biolog evalu and research food and drug administr div of immun nation center for prevent svc mening and special pathogen br div of bacteri and mycot diseas nation center for infecti diseas cdc refer adam wg deaver ka cochi sl et al declin of childhood haemophilu influenza type b hib diseas in the hib vaccin era jama broadhurst le erickson rl kellei pw decreas in invas haemophilu influenza diseas in u s armi children through jama murphi tv white ke pastor p et al declin incid of haemophilu influenza type b diseas sinc introduct of vaccin jama hicnet medic newslett page volum number april fritzel b plotkin s efficaci and safeti of a haemophilu influenza type b capsular polysaccharid tetanu protein conjug vaccin j pediatr acip haemophilu b conjug vaccin for prevent of haemophilu influenza type b diseas among infant and children two month of ag and older recommend of the immun practic advisori committe acip mmwr no rr acip diphtheria tetanu and pertussi recommend for vaccin us and other prevent measur recommend of the immun practic advisori committe acip mmwr no rr acip pertussi vaccin acellular pertussi vaccin for reinforc and booster us supplementari acip statement recommend of the immun practic advisori committe acip mmwr no rr acip pertussi vaccin acellular pertussi vaccin for the fourth and fifth dose of the dtp seri updat to supplementari acip statement recommend of the immun practic advisori committe acip mmwr no rr us of trade name and commerci sourc is for identif onli and doe not impli endors by the public health servic or the u s depart of health and human servic hicnet medic newslett page volum number april dental new intern workshop explor oral manifest of hiv infect nidr research digest written by jodi dove march nation institut of dental research at the second intern workshop on the oral manifest of hiv infect held januari februari in san francisco particip explor issu relat to the epidemiolog basic molecular virolog mucos immunolog and oral clinic present of hiv infect the workshop wa organ by dr john greenspan and dr deborah greenspan of the depart of stomatolog school of dentistri univers of california san francisco an intern steer committe and scientif program committe provid guidanc the confer drew more than scientist from countri includ asia africa europ central america south america as well as the unit state and canada support tor the workshop wa provid by the nation institut of dental research the nation cancer institut the nation institut of allergi and infecti diseas the nih offic of aid research and the procter and gambl compani among the topic discuss were the epidemiolog of hiv lesion ethic profession respons and public polici occup issu provis of oral care to the hiv posit popul salivari hiv transmiss and mucos immun opportunist infect pediatr hiv infect and women s issu recommend recommend emerg from the workshop to defin the associ between the appear of oral lesion and rate of progress of hiv to establish a univers terminolog for hiv associ oral lesion to look for more effect treatment for oral manifest to expand molecular biologi studi to understand the relationship between hiv infect and common oral lesion and to studi the effect of hiv therapi on oral lesion epidemiolog sinc the first intern workshop on oral manifest of hiv infect wa conven five year ago the epidemiolog of hiv infect ha hicnet medic newslett page volum number april radic chang in hiv infect wa detect and report larg in homosexu and bisexu male intraven drug user and hemophiliac todai more hiv infect is seen in heterosexu male and femal and in children and adolesc while the predomin impact of hiv infect ha been felt in africa a major increas in infect rate is be seen in southeast asia as well five hundr thousand case have been report to date in thi region and more ar appear all the time research ar continu to document the epidemiolog of oral lesion such as hairi leukoplakia and candidiasi thei also ar begin to explor the relationship between specif oral lesion and hiv diseas progress and prognosi social polit issu discuss on the social and polit implic of hiv infect focus on chang the public s attitud that aid is retribut for indiscrimin sexual behavior and drug us speaker also address health care deliveri for hiv infect patient and the need to educ the public about what aid is and how it is acquir saliva and salivari gland confer speaker describ transmiss issu and the hiv inhibitori activ of saliva the strength of which vari among the differ salivari secret whole saliva ha a greater inhibitori effect than submandibular secret which in turn have a greater inhibitori effect than parotid secret research ha shown that at least two mechan ar respons for salivari inhibitori activ thei attribut the hiv inhibitori effect of saliva to the aggreg agglutin of hiv by saliva which mai both promot clearanc of viru and prevent it reach a target cell and direct effect on the viru or target cell other topic discuss were the manifest of salivari gland diseas in hiv infect person and current research on oral mucos immun pediatr issu pediatr aid recent ha emerg as an area of intens interest with earli and accur diagnosi and proper treatment the life expect of hiv infect children ha tripl the prevent of transmiss of hiv from mother to child mai be possibl in mani case particularli if the mother s sero statu is known prior to give birth periodont and gingiv tissu diseas hicnet medic newslett page volum number april oral health research continu to explor periodont diseas and gingiv found in individu with hiv infect recommend made at the workshop includ the standard of terminolog refin of diagnost marker standard of studi design and proper consider of confound variabl result from periodont therapi occup and treatment issu occup issu surround the treatment of hiv infect individu and treatment render by hiv infect health care profession still command consider attent factor under consider includ the cost benefit of hiv test patient to health care provid transmiss of hiv infect and the revers and the us of mainstream versu dedic facil for the treatment of hiv infect patient confer particip anticip that a third intern workshop on the oral manifest of hiv infect will be held in five year or less proceed from the second workshop will be publish by the quintess compani in late end of part internet david stat com fax bitnet atw h asuacad fidonet amateur packet ax wb tpy wb tpy az usa na 